MMM 3M

Q1 2025 10-Q

Filed: Apr 22, 2025Period ending Mar 31, 2025

Health Care

Surgical & Medical Instruments & ApparatusSEC EDGAR

3M (MMM) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 22, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Management Discussion & Analysis

• Revenue and YoY change not disclosed in provided text
• Profitability or margin figures not included in excerpt

+3 more insights

Risk Factors

• New risk: PFAS manufacturing exit by end of 2025 triggered by December 2022 announcement, including $0.8B pre-tax charge for asset impairments in Q4 2022
• Material update: PFAS-related liabilities; $10.5B-$12.5B PWS Settlement payments from 2024-2036, with regulatory risks under CERCLA 2024 PFAS hazardous substance designation

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$6.0B

▼ -25.6% YoY

Net Income

$1.1B

▲ +20.3% YoY

Operating Margin

20.9%

▲ +217bp YoY

Net Margin

18.7%

▲ +715bp YoY

EPS (Diluted)

$2.04

▲ +22.2% YoY

Operating Cash Flow

-$79M

▼ -110.3% YoY

Source: XBRL data from 3M Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other 3M Quarterly Reports

Q3 2025 10-Q

Get deeper insights on 3M

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.